Latest Period
Q1 2026
Security Snapshot
60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SXTP) Institutional Ownership
CUSIP: 83006G401
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.61
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- SXTP on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 0
- Total 13F value
- $0
- Share change
- -44,358
- Value change
- -$22,547
- Number of holders
- 0
- Shares outstanding
- 4,285,676
- SEC-reported price per share
- $0.61
- Insider filing price
- $0.61
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SXTP - 60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 83006G401.
- 0 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 7 to 0 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $22,547 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 0 institutions filings for Q1 2026.
Security key
83006G401
Latest holder period
Q1 2026
13F holders
0
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
SXTP full holder history
60 DEGREES PHARMACEUTICALS, INC. SEC filings
60 DEGREES PHARMACEUTICALS, INC. company facts
60 DEGREES PHARMACEUTICALS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 83006G401:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
SXTP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 0% | $670,061 | +$187,456 | 455,545 | +39% | CVI Investments, Inc. | 30 Sep 2025 |
| Ayrton Capital LLC | 4.1% | -58% | $260,977 | +$20,515 | 177,427 | +8.5% | Ayrton Capital LLC | 30 Sep 2025 |
| Orca Capital AG | 4.9% | $382,327 | 166,229 | Orca Capital AG | 15 Jul 2025 | |||
| ARMISTICE CAPITAL, LLC | 5% | $226,656 | 77,357 | Armistice Capital, LLC | 31 Mar 2025 |
As of 31 Mar 2026, 0 institutional investors reported holding 0 shares of 60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SXTP). This represents 0% of the company’s total 4,285,676 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q1 2026
Rows shown
1-5 of 5